0001782959-21-000002.txt : 20210105 0001782959-21-000002.hdr.sgml : 20210105 20210105153453 ACCESSION NUMBER: 0001782959-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210105 DATE AS OF CHANGE: 20210105 EFFECTIVENESS DATE: 20210105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Capital Rx, Inc. CENTRAL INDEX KEY: 0001782959 IRS NUMBER: 352612946 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-385278 FILM NUMBER: 21505199 BUSINESS ADDRESS: STREET 1: 228 PARK AVENUE S. STREET 2: SUITE 87234 CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 855-538-8897 MAIL ADDRESS: STREET 1: 228 PARK AVENUE S. STREET 2: SUITE 87234 CITY: NEW YORK STATE: NY ZIP: 10003 D 1 primary_doc.xml X0708 D LIVE 0001782959 Capital Rx, Inc. 228 PARK AVENUE S. SUITE 87234 NEW YORK NY NEW YORK 10003 855-538-8897 DELAWARE Capital RX, LLC None Corporation true 2017 A. J. Loiacono 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Executive Officer Director Ryan Kelly 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Director Joseph Alexander 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Executive Officer Director Lenard Marcus 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Director Laura Alemzadeh 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Executive Officer Secretary Kevin Hill 4 Somerset Dr. Rumson NJ NEW JERSEY 07760 Director Jared Kesselheim c/o Transformation Capital, Attn: CFO 1 Federal Street, 25th Floor Boston MA MASSACHUSETTS 02110 Director Other Decline to Disclose 06b false 2020-12-21 false true false 0 52999994 31960628 21039366 Total offering amount consists of an initial closing of $31,960,627.84 and a milestone sale of $3,499,998.47 and up to an additional $17,539,367.40 at one or more subsequent closings with a right to purchase any remaining amount not sold. false 4 0 0 0 false Capital Rx, Inc. /s/ A.J. Loiacono A.J. Loiacono CEO 2021-01-05